The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%

Roots Analysis has done a detailed study on “Prefilled Syringe Fill / Finish Services Market, 2020-2030.”

, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

Key Market Insights

§  Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.

§  The market landscape features the presence of well- established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.

§  In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.

§  Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.

§  As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.

§  The demand for fill / finish services for prefilled syringes is likely to steadily increase in the coming years; we believe stakeholders may have to expand their respective capacities to ensure a consistent supply.

§  An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.

§  Caste Study: Around 70 prefilled syringes are being manufactured by large companies, most of  which claim to be capable of fabricating syringe barrels from both glass and plastic materials.

§  We expect drug developers to continue to outsource their fill / finish operations in the short to mid term, resulting in an annualized growth at the rate of over 8% within the contract services market.

§  In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.

For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

Table of Contents

1.         PREFACE
1.1.       Chapter Overview

1.2.       Scope of the Report

1.3.       Research Methodology

1.4.       Chapter Outlines

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

3.1.       Chapter Overview

3.2.       Introduction to Prefilled Syringes

3.2.1.    Classification of Prefilled Syringes

3.2.2.    Manufacturing of Prefilled Syringes

3.2.3.    Advantages of Prefilled Syringes

3.2.3.1. Benefits to Healthcare Professionals and End Users

3.2.3.2. Benefits to Manufacturers

3.3.       Fill / Finish Processing of Prefilled Syringes

3.3.1.    Steps Involved in Fill / Finish Process

3.3.2.    Methods of Filling and Stoppering of Prefilled Syringes

3.3.3.    Prefilled Syringe Filling Technologies

3.4.       Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market

3.5.       Need for Outsourcing Fill / Finish Operations of Sterile Injectables

3.6.       Advantages of Outsourcing Fill / Finish Services

3.7.       Risks Associated with Outsourcing of Fill / Finish Operations

3.8.       Key Considerations While Selecting a Fill / Finish Service Provider

4.         MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape

4.2.1.    Analysis by Year of Establishment

4.2.2.    Analysis by Company Size

4.2.3.    Analysis by Scale of Operation

4.2.4.    Analysis by Location of Headquarters

4.2.5.    Analysis by Location of Prefilled Syringe Fill / Finish  Facilities

4.2.6.    Analysis by Type of Drug Molecule

4.2.7.    Analysis by Syringe Barrel Material

4.2.8.    Analysis by Syringe Fill Volume

4.2.9.    Analysis by Additional Services Offered

4.2.10.  Heat Map: Analysis by Company Size and Location of Headquarters

4.2.11.  Logo Landscape: Analysis by Company Size and Type of Drug Molecule

4.2.12.  Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities

4.2.13.  Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule

5.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

5.1.       Chapter Overview

5.2.       Ajinomoto Bio-Pharma Services

5.2.1.    Company  Overview

5.2.2.    Recent Developments and Future Outlook

5.3.       AMRI

5.3.1.    Company  Overview

5.3.2.    Recent Developments and Future Outlook

5.4.       BioPharma Solutions

5.4.1.    Company  Overview

5.4.2.    Recent Developments and Future Outlook

5.5.       Emergent BioSolutions

5.5.1.    Company  Overview

5.5.2.    Recent Developments and Future Outlook

5.6.       Patheon (a  Thermo Fisher Scientific Company)

5.6.1.    Company  Overview

5.6.2.    Recent Developments and Future Outlook

6.         PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

6.1.       Chapter Overview

6.2.       Consort Medical

6.2.1.    Company  Overview

6.2.2.    Recent Developments and Future Outlook

6.3.       EVER Pharma

6.3.1.    Company  Overview

6.3.2.    Recent Developments and Future Outlook

6.4.       GlaxoSmithKline

6.4.1.    Company  Overview

6.4.2.    Recent Developments and Future Outlook

6.5.       IDT Biologika

6.5.1.    Company  Overview

6.5.2.    Recent Developments and Future Outlook

6.6.       Rentschler Biopharma

6.6.1.    Company  Overview

6.6.2.    Recent Developments and Future Outlook

6.7.       Siegfried

6.7.1.    Company  Overview

6.7.2.    Recent Developments and Future Outlook

6.8.       Vetter Pharma

6.8.1.    Company  Overview

6.8.2.    Recent Developments and Future Outlook

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com